RGNX · REGENXBIO Inc. · Share Buybacks
$7.74
+0.31 (+4.14%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 6, 2026
The latest filing no longer states the doubt (first flagged May 14, 2026).
View the 10-Q filed Aug 6, 2026Market Cap
$488.50M
Shares
66.01M
Volume · Oct 2
1.04M
Avg daily vol (3M)
1.58M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2024-12 | — | $150,000,000 | — | — | 10-Q , filed 2026-05-14 |